QQ客服 官方微博 反馈留言

浏览/检索结果: 共11条，第1-10条 帮助 限定条件 发表日期：2021     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 A Support Vector Machine Based on Liquid Immune Profiling Predicts Major Pathological Response to Chemotherapy Plus Anti-PD-1/PD-L1 as a Neoadjuvant Treatment for Patients With Resectable Non-Small Cell Lung Cancer 期刊论文 FRONTIERS IN IMMUNOLOGY, 2021, 卷号: 12 作者:  Peng, Jie;  Zou, Dan;  Han, Lijie;  Yin, Zuomin;  Hu, Xiao 收藏  |  浏览/下载：23/0  |  提交时间：2022/02/14 non-small cell lung cancer  support vector machine  major pathological response  liquid immune profiling  neoadjuvant treatment   Engineering Chameleon Prodrug Nanovesicles to Increase Antigen Presentation and Inhibit PD-L1 Expression for Circumventing Immune Resistance of Cancer 期刊论文 ADVANCED MATERIALS, 2021, 页码: 12 作者:  Zhou, Fengqi;  Gao, Jing;  Tang, Yang;  Zou, Zhifeng;  Jiao, Shi 收藏  |  浏览/下载：38/0  |  提交时间：2021/11/04 antigen presentation  autophagy inhibition  immune resistance  immunotherapy  prodrug nanovesicles   Acid-activatible micelleplex delivering siRNA-PD-L1 for improved cancer immunotherapy of CDK4/6 inhibition 期刊论文 CHINESE CHEMICAL LETTERS, 2021, 卷号: 32, 期号: 6, 页码: 1929-1936 作者:  Gao, Jing;  Zhang, Hanwu;  Zhou, Fengqi;  Hou, Bo;  Chen, Meiwan 收藏  |  浏览/下载：17/0  |  提交时间：2021/08/17 Cancer immunotherapy  siRNA delivery  Acid-activatible micelleplex  CDK4  6 inhibitor  PD-L1 knockdown   AdvanTIG-302: Anti-TIGIT monoclonal antibody (mAb) ociperlimab (OCI) plus tislelizumab (TIS) versus pembrolizumab (PEM) in programmed death ligand-1 (PD-L1) selected, previously untreated, locally advanced, unresectable or metastatic non-small cell lung cancer (NSCLC). 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39 作者:  Socinski, Mark A.;  Spira, Alexander I.;  Paz-Ares, Luis G.;  Reck, Martin;  Lu, Shun 收藏  |  浏览/下载：32/0  |  提交时间：2022/01/10 Neoadjuvant pembrolizumab with chemotherapy for the treatment of stage IIB-IIIB resectable lung squamous cell carcinoma 期刊论文 JOURNAL OF THORACIC DISEASE, 2021, 卷号: 13 作者:  Shen, Dijian;  Wang, Jiangfeng;  Wu, Jie;  Chen, Sheng;  Li, Jianqiang 收藏  |  浏览/下载：29/0  |  提交时间：2021/05/10 Neoadjuvant chemoimmunotherapy  lung squamous cell carcinoma (LUSC)  thoracic surgery  pembrolizumab   Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China 期刊论文 CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021 作者:  Zhang, Xiangyu;  Zeng, Liang;  Li, Yizhi;  Xu, Qinqin;  Yang, Haiyan 收藏  |  浏览/下载：29/0  |  提交时间：2021/03/15 Anlotinib  Immunotherapy  Programmed death 1 inhibitor  Lung cancer   Overcoming immune resistance by sequential prodrug nanovesicles for promoting chemoimmunotherapy of cancer 期刊论文 NANO TODAY, 2021, 卷号: 36, 页码: 12 作者:  Zhou, Fengqi;  Gao, Jing;  Xu, Zhiai;  Li, Tianliang;  Gao, Ang 收藏  |  浏览/下载：25/0  |  提交时间：2021/06/11 Tumor microenvironment  Prodrug nanovesicles  Cancer immunotherapy  Immunogenic cell death  Adaptive immune resistance   The safety and efficacy of neoadjuvant PD-1 inhibitor with chemotherapy for locally advanced esophageal squamous cell carcinoma 期刊论文 JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 卷号: 12 作者:  Shen, Dijian;  Chen, Qixun;  Wu, Jie;  Li, Jianqiang;  Tao, Kaiyi 收藏  |  浏览/下载：39/0  |  提交时间：2021/04/26 Neoadjuvant immunotherapy  esophageal squamous cell carcinoma (ESCC)  thoracic surgery  programmed death 1 (PD-1)   Safety and efficacy of combination therapy using programmed cell death protein-1/programmed cell death ligand-1 inhibitors and radiotherapy in patients with non-small-cell lung cancer: A systematic review and meta-analysis 期刊论文 CANCER MEDICINE, 2021, 页码: 19 作者:  Geng, Yichao;  Zhang, Qiuning;  Feng, Shuangwu;  Li, Chengcheng;  Wang, Lina 收藏  |  浏览/下载：27/0  |  提交时间：2021/12/10 combined radio-immunotherapy  meta-analysis  non-small-cell lung cancer  programmed cell death protein-1/programmed cell death ligand-1 inhibitors  radiotherapy  systematic review   Non-invasive measurement of PD-L1 status and prediction of immunotherapy response using deep learning of PET/CT images 期刊论文 JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 卷号: 9, 期号: 6, 页码: 15 作者:  Mu, Wei;  Jiang, Lei;  Shi, Yu;  Tunali, Ilke;  Gray, Jhanelle E. 收藏  |  浏览/下载：73/0  |  提交时间：2021/08/15 tumor biomarkers  immunotherapy